Grant ID | RP100146 |
Awarded On | January 20, 2010 |
Title | Imaging cancerous tissues with liposomal MRI contrast agents that utilize bioengineered nanovalves |
Program | Academic Research |
Award Mechanism | Individual Investigator |
Institution/Organization | The University of Texas Southwestern Medical Center |
Principal Investigator/Program Director | Paul Blount |
Cancer Sites | Multiple Sites |
Contracted Amount | $1,144,531 |
Lay Summary |
Early detection of aggressive malignancies such as pancreatic cancer is critically important for successful treatment outcomes. While several imaging modalities have advanced the field, there is still a great need for improved sensitivity and accurate early detection of pancreatic cancer and other aggressive malignancies. The fundamental goal of this proposal is to design and construct responsive or “smart” magnetic resonance imaging (MRI) nanoprobes for high resolution in vivo cancer imaging and early detection. Normally, MRI contrast agents work by modifying the water exchange rate, which can vary in different parts of the body. We propose to use a biological pore, which we will engineer to ... |